PharmiWeb Recruiter Blog

In this article, we’ve put together a list of the best life science organisations to work for in the UK, using the official rankings awarded by The Great Place to Work Institute in 2023.

INDIANAPOLIS and NEW YORK, July 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases.

Supporting You with UC Provides Patients with Resources to Help Manage Their UC and Tips on Ways to Communicate with Their Doctor

AI is already transforming the recruitment landscape, with 85% of recruiters agreeing that this technology is a useful tool in the hiring process. New developments and use cases for AI are being unleashed at an astonishing rate, and if you aren’t already looking at how you can use this technology to your advantage, now is the time to do so.

• Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform
• Expected to Be Immediately Accretive to Adjusted Earnings Per Share ¹

WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity (“Audax”), for $912.5 million in cash.

In today’s competitive job market and taxing economy, finding the right talent for your organisation whilst sticking to tight budgets can be a real challenge – yet it’s not impossible. By implementing cost-effective strategies, you can streamline your hiring procedures, attract qualified candidates, and make efficient use of your resources.

BURLINGTON, N.C., July 3, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that it has completed the spin-off of Fortrea, the newly formed independent Contract Research Organization providing Phase I-IV clinical trial management, patient access and technology solutions to pharmaceutical and biotechnology organizations around the world. Fortrea will begin trading on the NASDAQ Stock Market under the symbol "FTRE" effective at the market opening today.

As a recruiter or hiring manager in the life science industry, identifying the strongest job candidate requires a comprehensive evaluation of not only hard skills, qualifications, and experiences, but soft skills too.

• Expansion of AZ Forest programme raises commitment to plant 200 million trees across six continents by 2030
• New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia

AstraZeneca has announced a $400 million investment in its global AZ Forest programme, raising its commitment to plant 200 million trees by 2030 and ensure their long-term survival. This includes new or expanded projects in Brazil, India, Vietnam, Ghana and Rwanda that will contribute to the Company’s climate action, restore nature, promote biodiversity and build ecological and community resilience, spanning over 100,000 hectares worldwide.

Becoming the preferred partner in a challenging economy